Effects of a controlled program of moderate physical exercise on insulin sensitivity in nonobese, nondiabetic subjects

Clinical Journal of Sport Medicine

Volumn 16, Issue 1, 2006, Pages 46-50

  Hasbum, Berhart ^a   Real, Jose T ^a   Sánchez, Carlos ^a   Priego, Maria A ^a   Díaz, Juan ^a   Viguer, Angeles ^a   Basanta, Marisa ^a   Martínez Valls, Jose ^a   Marín, Julio ^a   Carmena, Rafael ^a   Ascaso, Juan F ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Aerobic exercise; Exercise and insulin resistance; Insulin resistance; Minimal model

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; LEPTIN; LIPID;

ADULT; AEROBIC EXERCISE; ARTICLE; BASAL METABOLIC RATE; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; EXERCISE INTENSITY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE PERSONNEL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; OXYGEN CONSUMPTION; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; WAIST HIP RATIO;

ADULT; BODY MASS INDEX; BODY WEIGHT; EXERCISE THERAPY; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OXYGEN CONSUMPTION;

EID: 30344473897     PISSN: 1050642X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jsm.0000180021.67759.16     Document Type: Article

References (36)

1. Reaven GM. Banting Lecture: role of insulin resistance in human disease. Diabetes. 1998;37:1595-1607.
2. Reaven GM. Syndrome X: 6 years later. J Intern Med. 1994;235(suppl 736):3-22.
3. Jensen MD, Haymond MW, Rizza RA, et al. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest. 1989;83:1168-1173.
4. Roden M, Price TB, Perseghin G, et al. Mechanism of free fatty acid-induced insulin resistance in human. J Clin Invest. 1996;97:2859-2865.
5. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes. 1997;46:3-10.
6. Bonadonna C, Bonora E. Glucose and free fatty acid metabolism in human obesity: relationships to insulin resistance. Diabetes Rev. 1997;5:21-51.
7. Ota T, Takamura T, Iría N, et al. Preobesity in World Health Organization classification involves metabolic syndrome in Japanese. Diabetes Care. 2002;25:1252-1253.
8. Ruderman NB, Chisholm D, Pi-Sunyer X, et al. The metabolically-obese, normal weight individual. Diabetes. 1998;47:699-713.
9. Eriksson KF, Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise: the 6-year Malmo feasibility study. Diabetologia. 1991;34:891-898.
10. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537-544.
11. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Finnish Diabetes Prevention Study Group: prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-1350.
12. Diabetes Prevention Research Group. Reduction in the evidence of type 2 diabetes with life-style intervention or metformin. N Engl J Med. 2002;346:393-403.
13. Usui K, Yamanouchi K, Asai K, et al. The effect of low intensity bicycle exercise on the insulin-induced glucose uptake in obese patients with type 2 diabetes. Diabetes Res Clin Pract. 1998;41:57-61.
14. Ebeling P, Bourey R, Koranyi L, et al. Mechanism of enhanced insulin sensitivity in athletes: increased blood flow, muscle glucose transport protein (GLUT4) concentration and glycogen synthase activity. J Clin Invest. 1993;92:1623-1631.
15. Shepherd PR, Kahn BB. Glucose transporters and insulin action. N Engl J Med. 1999;341:248-257.
16. Trinder P. Enzymatic colorimetric method for glucose determination. Ann Clin Biochem. 1969;6:24-27.
17. Allain CC, Poon LS, Chan CSG, et al. Enzymatic determination of total serum cholesterol. Clin Chem. 1997;20:470-475.
18. Ter HF, Baarscheer T, Fiolet JWT. Influence of free glycerol on enzymatic of triglycerides. Clin Chem. 1984;30:1102-1103.
19. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970;11:583-595.
20. Rosseneau M, Verchemst R, Steinberg KK, et al. Some considerations of methodology and standardization of apolipoprotein B immunoassays. Clin Chem. 1983;29:427-433.
21. Milies J, Glasscock R, Aikens J, et al. A microflurimetric method for the determination of free fatty acids in plasma. J Lipid Res. 1983;24:96-99.
22. Alpha B, Cox L, Crowther N, et al. Sensitive amplified immunoenzymometric assays (IEMA) for human insulin and intact proinsulin. Eur J Clin Chem Clin Biochem. 1992;30:27-32.
23. Considine RV, Sinha MK. Serum immunoreactive-leptin concentrations on normal weight and obese humans. N Engl J Med. 1996;334:292-295.
24. Ascaso JF, Merchante A, Llorente RI, et al. A study of insulin resistance using the minimal model in non-diabetic familial combined hyper-lipidemic patients. Metabolism. 1998;47:508-513.
25. Gimenez M, Salinas W, Cervera E, et al. V02 max during progressive and constant bicycle exercise in sedentary men and women. Eur J Appl Physiol. 1981;46:237-248.
26. American College of Sports Medicine. Position stand on "The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness in healthy adults." Med Sci Sports Exerc. 1990;22:265-274.
27. Howard BV, Rodriguez BL, Bennett PH, et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group I: Epidemiology. Circulation. 2002;105:132-137.
28. Ascaso JF, Romero P, Real JT, et al. Abdominal adiposity (waist circumference) and its relation to insulin resistance and the metabolic syndrome in a South European population. Eur J Intern Med. 2003;14:101-106.
29. Ruderman NB, Berchtold P, Schneider SH. Obesity-associated disorders in normal weight individuals: some speculations. Int J Obes. 1982;6(suppl 1):151-157.
30. Caro JF. Insulin resistance in obese and non-obese men. J Clin Endocrinol Metab. 1991;73:691-695.
31. Eriksson J, Taimela S, Koivisto VA. Exercise and the metabolic syndrome. Diabetologia. 1997;40:125-135.
32. Castro Cabezas M, Halkes CJ, Erkelens DW. Obesity and free fatty acids: double trouble. Nutr Metab Cardiovasc Dis. 2001;11:134-142.
33. Angelopoulos TJ, Schultz RM, Denton JC, et al. Significant enhancements in glucose tolerance and insulin action in centrally obese subjects following ten days of training. Clin J Sport Med. 2002;12:113-118.
34. Shepherd J, Cobbe SM, Ford I, et al, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301-1307.
35. Festa A, D'Agostino R Jr, Williams K, et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord. 1991;25:1407-1415.
36. Lindstrom J, Louheranta A, Mannelin M, et al. Finnish Diabetes Prevention Study Group. The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003;26:3230-3236.